NewAmsterdam Pharma Co N.V. (NAMS): SCHEDULE 13D/A filed May 14, 2026

Form type

SCHEDULE 13D/A

Filing date

May 14, 2026

Accession number

0001193125-26-224656

Filer

NewAmsterdam Pharma Co N.V. (CIK 1936258)